Lumina Fund Management’s Editas Medicine EDIT Stock Holding History

Lumina Fund Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,500	Closed	-$86K	–	62
2023 Q2	$86K	Hold	10,500	–	–	0.04%	69
2023 Q1	$76K	Hold	10,500	–	–	0.04%	71
2022 Q4	$93K	Hold	10,500	–	–	0.04%	71
2022 Q3	$129K	Hold	10,500	–	–	0.05%	69
2022 Q2	$124K	Hold	10,500	–	–	0.05%	65
2022 Q1	$200K	Buy	+10,500	New	+$195K	0.06%	55

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lumina Fund Management's EDIT Position: Q3 2023 in Review

Lumina Fund Management sold out of Editas Medicine (EDIT) in Q3 2023, closing a stake of 10,500 shares — an estimated $86K sold.

Lumina Fund Management first reported a position in EDIT in Q1 2022 and held it in 6 quarters. The position peaked at $200K in Q1 2022. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2023.

Lumina Fund Management reported no remaining Editas Medicine position as of Q3 2023 after selling out during the quarter.
Lumina Fund Management sold 10,500 Editas Medicine shares in Q3 2023, an estimated $86K.
Lumina Fund Management first reported a position in Editas Medicine in Q1 2022 and held it in 6 quarters.
Lumina Fund Management's Editas Medicine position peaked at $200K in Q1 2022.
220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2023.

Based on Lumina Fund Management's 13F filing for Q3 2023, filed 13 Nov 2023.